Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on December 8, 2003

Hypertension. 2003
Published online before print December 8, 2003, doi: 10.1161/01.HYP.0000107778.85528.b5
A more recent version of this article appeared on February 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/2/249    most recent
01.HYP.0000107778.85528.b5v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alemany, R.
Right arrow Articles by Escribá, P. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alemany, R.
Right arrow Articles by Escribá, P. V.

Submitted on September 22, 2003
Revised on October 15, 2003

2-Hydroxyoleic Acid. A New Hypotensive Molecule

Regina Alemany; Silvia Terés; Carmela Baamonde; Mikhail Benet; Oliver Vögler; and Pablo V. Escribá*

From the Laboratory of Molecular and Cellular Biomedicine, IUNICS, Department of Biology, Associate Unit of the Instituto de la Grasa (CSIC), University of the Balearic Islands, Palma de Mallorca, Spain.

* To whom correspondence should be addressed. E-mail: pablo.escriba{at}uib.es.

Abstract--Recent studies have shown that diets rich in monounsaturated fatty acids (MUFAs) from olive oil, a natural source of oleic acid, have beneficial effects on blood pressure (BP) in hypertensive patients. With this in mind, we investigated whether a synthetic derivative of the MUFA oleic acid, 2-hydroxyoleic acid (2-OHOA), was capable of regulating the BP of Sprague-Dawley rats. Intraperitoneal and oral administration of 2-OHOA to rats induced significant and sustained decreases in BP in a time-dependent manner. Without affecting heart rate, treatments for 7 days provoked reductions in systolic BP of 20 to 26 mm Hg. At the molecular level, the density of G{alpha}s, but not G{alpha}i2 or G{alpha}o, increased in membranes from the hearts and aortas of 2-OHOA-treated rats, whereas in heart membranes, the density of G{alpha}q/11 and protein kinase C{alpha} proteins was also augmented. These molecular alterations were reflected in the increase in cAMP levels after G{alpha}s protein and {beta}-adrenergic receptor stimulation. On the contrary, inhibitory hormones reduced adenylyl cyclase activity to the same extent in 2-OHOA-treated rats as in vehicle-treated ones. Our results indicate that cardiovascular tissues from 2-OHOA-treated rats exhibited increased cAMP production in response to G{alpha}s activation, which might be attributed to enhanced expression of G{alpha}s proteins. As a result of this change, a significant reduction in systolic BP was observed. Therefore, BP can be lowered by administration of 2-OHOA, which might represent the first member of a new family of antihypertensive drugs.


Key words: blood pressure • fatty acids • signal transduction • G proteins • hypotension




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Teres, G. Barcelo-Coblijn, M. Benet, R. Alvarez, R. Bressani, J. E. Halver, and P. V. Escriba
Oleic acid content is responsible for the reduction in blood pressure induced by olive oil
PNAS, September 16, 2008; 105(37): 13811 - 13816.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. H. Borchert, M. Giggey, F. Kolar, T. M. Wong, P. H. Backx, and P. V. Escriba
2-Hydroxyoleic acid affects cardiomyocyte [Ca2+]i transient and contractility in a region-dependent manner
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1948 - H1955.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. Alemany, O. Vogler, S. Teres, C. Egea, C. Baamonde, F. Barcelo, C. Delgado, K. H. Jakobs, and P. V. Escriba
Antihypertensive action of 2-hydroxyoleic acid in SHRs via modulation of the protein kinase A pathway and Rho kinase
J. Lipid Res., August 1, 2006; 47(8): 1762 - 1770.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Martinez, A. Gutierrez, J. Casas, V. Llado, A. Lopez-Bellan, J. Besalduch, A. Dopazo, and P. V. Escriba
The Repression of E2F-1 Is Critical for the Activity of Minerval against Cancer
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 466 - 474.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Q. Yang, R. Alemany, J. Casas, K. Kitajka, S. M. Lanier, and P. V. Escriba
Influence of the Membrane Lipid Structure on Signal Processing via G Protein-Coupled Receptors
Mol. Pharmacol., July 1, 2005; 68(1): 210 - 217.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
T. Psaltopoulou, A. Naska, P. Orfanos, D. Trichopoulos, T. Mountokalakis, and A. Trichopoulou
Olive oil, the Mediterranean diet, and arterial blood pressure: the Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study
Am. J. Clinical Nutrition, October 1, 2004; 80(4): 1012 - 1018.
[Abstract] [Full Text] [PDF]